speb/financial-data huggingface dataset:
NMR income_statement (annual, 2023-03-31) — Operating Revenue: 1144971000000.00
NMR balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 3003679324.00
NMR balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 708548000000.00
NMR balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 18556000000.00
NMR cash_flow (annual, 2023-03-31) — Other Non Cash Items: -375318000000.00
NMR income_statement (annual, 2023-03-31) — Other Non Interest Expense: 393878000000.00
NMR balance_sheet (annual, 2023-03-31) — Other Payable: 1799585000000.00
NMR balance_sheet (annual, 2023-03-31) — Other Receivables: 1116192000000.00
NMR income_statement (annual, 2023-03-31) — Other Special Charges: 344000000.00
NMR balance_sheet (annual, 2023-03-31) — Payables: 3201787000000.00
NMR balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 3681278000000.00
NMR balance_sheet (annual, 2023-03-31) — Prepaid Assets: 19727000000.00
NMR income_statement (annual, 2023-03-31) — Pretax Income: 149474000000.00
NMR cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
NMR cash_flow (annual, 2023-03-31) — Purchase Of Investment: -75500000000.00
NMR cash_flow (annual, 2023-03-31) — Purchase Of PPE: -171165000000.00
NMR balance_sheet (annual, 2023-03-31) — Receivables: 1496103000000.00
NMR income_statement (annual, 2023-03-31) — Reconciled Depreciation: 61424000000.00
NMR cash_flow (annual, 2023-03-31) — Repayment Of Debt: -3862674000000.00
NMR cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -24728000000.00
NMR balance_sheet (annual, 2023-03-31) — Retained Earnings: 1647005000000.00
NMR income_statement (annual, 2023-03-31) — Salaries And Wages: 605787000000.00
NMR cash_flow (annual, 2023-03-31) — Sale Of Business: 16950000000.00
NMR cash_flow (annual, 2023-03-31) — Sale Of Investment: 301066000000.00
NMR cash_flow (annual, 2023-03-31) — Sale Of PPE: 63648000000.00
NMR income_statement (annual, 2023-03-31) — Selling General And Administration: 605787000000.00
NMR balance_sheet (annual, 2023-03-31) — Share Issued: 3233562601.00
NMR cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 2630083000000.00
NMR cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -2694588000000.00
NMR income_statement (annual, 2023-03-31) — Special Income Charges: 23545000000.00
NMR cash_flow (annual, 2023-03-31) — Stock Based Compensation: 35216000000.00
NMR balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3148567000000.00
NMR balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3112373000000.00
NMR income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 9111915000.00
NMR income_statement (annual, 2023-03-31) — Tax Provision: 57798000000.00
NMR income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.39
NMR balance_sheet (annual, 2023-03-31) — Total Assets: 47771802000000.00
NMR balance_sheet (annual, 2023-03-31) — Total Capitalization: 13882096000000.00
NMR balance_sheet (annual, 2023-03-31) — Total Debt: 11935953000000.00
NMR balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3224142000000.00
NMR balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 44547660000000.00
NMR balance_sheet (annual, 2023-03-31) — Total Tax Payable: 42254000000.00
NMR income_statement (annual, 2023-03-31) — Total Unusual Items: 23545000000.00
NMR income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 23545000000.00
NMR balance_sheet (annual, 2023-03-31) — Trading Securities: 11853308000000.00
NMR balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 229883277.00
NMR balance_sheet (annual, 2023-03-31) — Treasury Stock: 118574000000.00
NMR income_statement (annual, 2024-03-31) — +Total Revenue: 1378017000000.00
NMR balance_sheet (annual, 2024-03-31) — Accounts Payable: 1310825000000.00
NMR balance_sheet (annual, 2024-03-31) — Accounts Receivable: 453937000000.00
NMR balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -529605000000.00
NMR balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 708785000000.00
NMR balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 739880000000.00
NMR income_statement (annual, 2024-03-31) — Average Dilution Earnings: -162000000.00
NMR income_statement (annual, 2024-03-31) — Basic Average Shares: 3017128412.00
NMR income_statement (annual, 2024-03-31) — Basic EPS: 54.97
NMR cash_flow (annual, 2024-03-31) — Beginning Cash Position: 3820852000000.00
NMR cash_flow (annual, 2024-03-31) — Capital Expenditure: -145784000000.00
NMR balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 189814000000.00
NMR balance_sheet (annual, 2024-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5154971000000.00
NMR balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 20776103000000.00
NMR cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -60164000000.00
NMR balance_sheet (annual, 2024-03-31) — Cash Financial: 4239359000000.00
NMR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 1012850000000.00
NMR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -887938000000.00
NMR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 132640000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Account Payable: 709839000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Accrued Expense: 26480000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Income Tax Payable: 70892000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Other Working Capital: -1105947000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Payable: 780731000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 807211000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Tax Payable: 70892000000.00
NMR cash_flow (annual, 2024-03-31) — Change In Working Capital: -283951000000.00
NMR cash_flow (annual, 2024-03-31) — Changes In Cash: 257552000000.00
NMR balance_sheet (annual, 2024-03-31) — Commercial Paper: 224801000000.00
NMR balance_sheet (annual, 2024-03-31) — Common Stock: 594493000000.00
NMR cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -60164000000.00
NMR balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3350189000000.00
NMR cash_flow (annual, 2024-03-31) — Common Stock Issuance: 953000000.00
NMR cash_flow (annual, 2024-03-31) — Common Stock Payments: -61029000000.00
NMR balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 596684000000.00
NMR balance_sheet (annual, 2024-03-31) — Current Debt: 1054717000000.00
NMR balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1054717000000.00
NMR cash_flow (annual, 2024-03-31) — Deferred Income Tax: -312000000.00
NMR cash_flow (annual, 2024-03-31) — Deferred Tax: -312000000.00
NMR cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 61340000000.00
NMR cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 61340000000.00
NMR income_statement (annual, 2024-03-31) — Diluted Average Shares: 3147902828.00
NMR income_statement (annual, 2024-03-31) — Diluted EPS: 52.69
NMR income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 165701000000.00
NMR cash_flow (annual, 2024-03-31) — Earnings Losses From Equity Investments: -31070000000.00
NMR cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 220618000000.00
NMR cash_flow (annual, 2024-03-31) — End Cash Position: 4299022000000.00
NMR cash_flow (annual, 2024-03-31) — Financing Cash Flow: 1012850000000.00
NMR cash_flow (annual, 2024-03-31) — Free Cash Flow: -13144000000.00
NMR cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -9612000000.00
NMR cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: -968000000.00
NMR cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 2670000000.00
NMR income_statement (annual, 2024-03-31) — Gain On Sale Of Business: 968000000.00
NMR income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 21489000000.00
NMR balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 459984000000.00
NMR income_statement (annual, 2024-03-31) — General And Administrative Expense: 673523000000.00
NMR balance_sheet (annual, 2024-03-31) — Goodwill: 19260000000.00
NMR balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 38387000000.00
NMR balance_sheet (annual, 2024-03-31) — Gross PPE: 978390000000.00
NMR cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 26050000000.00
NMR balance_sheet (annual, 2024-03-31) — Income Tax Payable: 81585000000.00
NMR income_statement (annual, 2024-03-31) — Interest Expense: 2595294000000.00
NMR income_statement (annual, 2024-03-31) — Interest Income: 2620856000000.00
NMR cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 2514801000000.00
NMR balance_sheet (annual, 2024-03-31) — Invested Capital: 17250227000000.00
NMR cash_flow (annual, 2024-03-31) — Investing Cash Flow: -887938000000.00
NMR balance_sheet (annual, 2024-03-31) — Investments And Advances: 13959465000000.00
NMR cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 953000000.00
NMR cash_flow (annual, 2024-03-31) — Issuance Of Debt: 5086964000000.00
NMR balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 189814000000.00
NMR balance_sheet (annual, 2024-03-31) — Long Term Debt: 12845321000000.00
NMR balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 13035135000000.00
NMR cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3122009000000.00
NMR cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2190046000000.00
NMR balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 572154000000.00
NMR balance_sheet (annual, 2024-03-31) — Minority Interest: 98324000000.00
NMR income_statement (annual, 2024-03-31) — Minority Interests: -11357000000.00
NMR cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -457000000.00
NMR cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -60076000000.00
NMR balance_sheet (annual, 2024-03-31) — Net Debt: 8745067000000.00
NMR income_statement (annual, 2024-03-31) — Net Income: 165863000000.00
NMR income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 165863000000.00
NMR income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 177220000000.00
NMR income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 165863000000.00
NMR income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 165863000000.00
NMR cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 177220000000.00
NMR income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 177220000000.00
NMR income_statement (annual, 2024-03-31) — Net Interest Income: 25562000000.00
NMR cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 20155000000.00
NMR cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1029920000000.00
NMR cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 931963000000.00
NMR cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -4362000000.00
NMR cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 914000000.00
NMR balance_sheet (annual, 2024-03-31) — Net PPE: 448785000000.00
NMR cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -33830000000.00
NMR cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 97957000000.00
NMR balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 3311802000000.00
NMR balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 85301000000.00
NMR balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 85301000000.00
NMR income_statement (annual, 2024-03-31) — Normalized Income: 166964194000.00
NMR income_statement (annual, 2024-03-31) — Occupancy And Equipment: 68698000000.00
NMR cash_flow (annual, 2024-03-31) — Operating Cash Flow: 132640000000.00
NMR cash_flow (annual, 2024-03-31) — Operating Gains Losses: -38980000000.00
NMR income_statement (annual, 2024-03-31) — Operating Revenue: 1378017000000.00
NMR balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 2970755160.00
NMR balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 829916000000.00
NMR balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 19127000000.00
NMR cash_flow (annual, 2024-03-31) — Other Non Cash Items: 167836000000.00
NMR income_statement (annual, 2024-03-31) — Other Non Interest Expense: 405931000000.00
NMR balance_sheet (annual, 2024-03-31) — Other Payable: 2823100000000.00
NMR balance_sheet (annual, 2024-03-31) — Other Receivables: 1229571000000.00
NMR income_statement (annual, 2024-03-31) — Other Special Charges: 2670000000.00
NMR balance_sheet (annual, 2024-03-31) — Payables: 4215510000000.00
NMR balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 4812194000000.00
NMR balance_sheet (annual, 2024-03-31) — Prepaid Assets: 22811000000.00
NMR income_statement (annual, 2024-03-31) — Pretax Income: 273850000000.00
NMR cash_flow (annual, 2024-03-31) — Purchase Of Business: -457000000.00
NMR cash_flow (annual, 2024-03-31) — Purchase Of Investment: -156932000000.00
NMR cash_flow (annual, 2024-03-31) — Purchase Of PPE: -145784000000.00
NMR balance_sheet (annual, 2024-03-31) — Receivables: 1683508000000.00
NMR income_statement (annual, 2024-03-31) — Reconciled Depreciation: 61340000000.00
NMR cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4057044000000.00
NMR cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -61029000000.00
NMR balance_sheet (annual, 2024-03-31) — Retained Earnings: 1705725000000.00
NMR income_statement (annual, 2024-03-31) — Salaries And Wages: 673523000000.00
NMR cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
NMR cash_flow (annual, 2024-03-31) — Sale Of Investment: 177087000000.00
NMR cash_flow (annual, 2024-03-31) — Sale Of PPE: 111954000000.00
NMR income_statement (annual, 2024-03-31) — Selling General And Administration: 673523000000.00
NMR balance_sheet (annual, 2024-03-31) — Share Issued: 3163562601.00
NMR cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 1964955000000.00
NMR cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -1866998000000.00
NMR income_statement (annual, 2024-03-31) — Special Income Charges: -1702000000.00
NMR cash_flow (annual, 2024-03-31) — Stock Based Compensation: 35577000000.00
NMR balance_sheet (annual, 2024-03-31) — Stockholders Equity: 3350189000000.00
NMR balance_sheet (annual, 2024-03-31) — Tangible Book Value: 3311802000000.00
NMR income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -600806000.00
NMR income_statement (annual, 2024-03-31) — Tax Provision: 96630000000.00
NMR income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.35
NMR balance_sheet (annual, 2024-03-31) — Total Assets: 55147203000000.00
NMR balance_sheet (annual, 2024-03-31) — Total Capitalization: 16195510000000.00
NMR balance_sheet (annual, 2024-03-31) — Total Debt: 14089852000000.00
NMR balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 3448513000000.00
NMR balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 51698690000000.00
NMR balance_sheet (annual, 2024-03-31) — Total Tax Payable: 81585000000.00
NMR income_statement (annual, 2024-03-31) — Total Unusual Items: -1702000000.00
NMR income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -1702000000.00
NMR balance_sheet (annual, 2024-03-31) — Trading Securities: 12647431000000.00
NMR balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 192807441.00
NMR balance_sheet (annual, 2024-03-31) — Treasury Stock: 118798000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 168503000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 469366000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 30878000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 58493000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 168503000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 101509000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 101509000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 27142000000.00
NMR balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 58493000000.00
NMR income_statement (quarterly, 2024-12-31) — +Total Revenue: 458336000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1439125000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 452997000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -562015000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 694693000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 613633000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 5574514000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 21848872000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Cash Financial: 4593764000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Common Stock: 594493000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 3569930000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Current Debt: 992255000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 992255000000.00
NMR income_statement (quarterly, 2024-12-31) — Diluted EPS: 33.08
NMR income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 3251000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 528816000000.00
NMR income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 190888000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1031503000000.00
NMR income_statement (quarterly, 2024-12-31) — Interest Expense: 695957000000.00
NMR income_statement (quarterly, 2024-12-31) — Interest Income: 745459000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Invested Capital: 18978855000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 24883439000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 14416670000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 14416670000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 640157000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Minority Interest: 105176000000.00
NMR income_statement (quarterly, 2024-12-31) — Minority Interests: -2701000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Net Debt: 9834411000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 104142000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 104142000000.00
NMR income_statement (quarterly, 2024-12-31) — Net Interest Income: 49502000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Net PPE: 469488000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 3569930000000.00
NMR income_statement (quarterly, 2024-12-31) — Normalized Income: 101441000000.00
NMR income_statement (quarterly, 2024-12-31) — Occupancy And Equipment: 17885000000.00
NMR income_statement (quarterly, 2024-12-31) — Operating Revenue: 458336000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 2955711756.00
NMR balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 992255000000.00
NMR income_statement (quarterly, 2024-12-31) — Other Non Interest Expense: 111284000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Other Payable: 3226450000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1110411000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Payables: 4665575000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 4665575000000.00
NMR income_statement (quarterly, 2024-12-31) — Pretax Income: 138279000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Receivables: 1563408000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 1895951000000.00
NMR income_statement (quarterly, 2024-12-31) — Salaries And Wages: 190888000000.00
NMR income_statement (quarterly, 2024-12-31) — Selling General And Administration: 190888000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Share Issued: 3163562601.00
NMR balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 3569930000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 3569930000000.00
NMR income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (quarterly, 2024-12-31) — Tax Provision: 34137000000.00
NMR income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
NMR balance_sheet (quarterly, 2024-12-31) — Total Assets: 60529845000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 17986600000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Total Debt: 15408925000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 3675106000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 56854739000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Trading Securities: 23629649000000.00
NMR balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 207850845.00
NMR balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 144023000000.00
NMR income_statement (annual, 2025-03-31) — +Total Revenue: 1662374000000.00
NMR income_statement (quarterly, 2025-03-31) — +Total Revenue: 355223000000.00
NMR balance_sheet (annual, 2025-03-31) — Accounts Payable: 1377222000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1377222000000.00
NMR balance_sheet (annual, 2025-03-31) — Accounts Receivable: 410722000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 410722000000.00
NMR balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -546117000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -546117000000.00
NMR balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 704877000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 704877000000.00
NMR balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 886392000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 886392000000.00
NMR income_statement (annual, 2025-03-31) — Average Dilution Earnings: -273000000.00
NMR income_statement (annual, 2025-03-31) — Basic Average Shares: 2955204882.00
NMR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2955646817.00
NMR income_statement (annual, 2025-03-31) — Basic EPS: 115.30
NMR income_statement (quarterly, 2025-03-31) — Basic EPS: 24.35
NMR cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4299022000000.00
NMR cash_flow (annual, 2025-03-31) — Capital Expenditure: -189971000000.00
NMR balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 174132000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 174132000000.00
NMR balance_sheet (annual, 2025-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5514696000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5514696000000.00
NMR balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 19519453000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 19519453000000.00
NMR cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -112541000000.00
NMR balance_sheet (annual, 2025-03-31) — Cash Financial: 4424462000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Cash Financial: 4424462000000.00
NMR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1679697000000.00
NMR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -848647000000.00
NMR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -678611000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Accrued Expense: 26496000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Income Tax Payable: 19235000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Other Working Capital: -2070355000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Payable: 2510000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 29006000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Tax Payable: 19235000000.00
NMR cash_flow (annual, 2025-03-31) — Change In Working Capital: -1112189000000.00
NMR cash_flow (annual, 2025-03-31) — Changes In Cash: 152439000000.00
NMR balance_sheet (annual, 2025-03-31) — Commercial Paper: 113765000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 113765000000.00
NMR balance_sheet (annual, 2025-03-31) — Common Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Common Stock: 594493000000.00
NMR cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -112541000000.00
NMR balance_sheet (annual, 2025-03-31) — Common Stock Equity: 3470879000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3470879000000.00
NMR cash_flow (annual, 2025-03-31) — Common Stock Issuance: 1412000000.00
NMR cash_flow (annual, 2025-03-31) — Common Stock Payments: -59006000000.00
NMR balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 551064000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 551064000000.00
NMR balance_sheet (annual, 2025-03-31) — Current Debt: 1117292000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Current Debt: 1117292000000.00
NMR balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1117292000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1117292000000.00
NMR cash_flow (annual, 2025-03-31) — Deferred Income Tax: 11559000000.00
NMR cash_flow (annual, 2025-03-31) — Deferred Tax: 11559000000.00
NMR cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 61653000000.00
NMR cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 61653000000.00
NMR income_statement (annual, 2025-03-31) — Diluted Average Shares: 3068864271.00
NMR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3076955964.00
NMR income_statement (annual, 2025-03-31) — Diluted EPS: 111.03
NMR income_statement (quarterly, 2025-03-31) — Diluted EPS: 23.39
NMR income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 340463000000.00
NMR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 71697000000.00
NMR cash_flow (annual, 2025-03-31) — Earnings Losses From Equity Investments: -34605000000.00
NMR cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -26020000000.00
NMR cash_flow (annual, 2025-03-31) — End Cash Position: 4425441000000.00
NMR cash_flow (annual, 2025-03-31) — Financing Cash Flow: 1679697000000.00
NMR cash_flow (annual, 2025-03-31) — Free Cash Flow: -868582000000.00
NMR cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -444000000.00
NMR cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: -205000000.00
NMR cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 2344000000.00
NMR income_statement (annual, 2025-03-31) — Gain On Sale Of Business: 205000000.00
NMR income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 8078000000.00
NMR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1188000000.00
NMR balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 447808000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 447808000000.00
NMR income_statement (annual, 2025-03-31) — General And Administrative Expense: 732390000000.00
NMR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 172321000000.00
NMR balance_sheet (annual, 2025-03-31) — Goodwill: 17199000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Goodwill: 17199000000.00
NMR balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 73345000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 73345000000.00
NMR balance_sheet (annual, 2025-03-31) — Gross PPE: 982571000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Gross PPE: 982571000000.00
NMR cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 93915000000.00
NMR balance_sheet (annual, 2025-03-31) — Income Tax Payable: 88424000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 88424000000.00
NMR income_statement (annual, 2025-03-31) — Interest Expense: 2844258000000.00
NMR income_statement (quarterly, 2025-03-31) — Interest Expense: 626619000000.00
NMR income_statement (annual, 2025-03-31) — Interest Income: 2927861000000.00
NMR income_statement (quarterly, 2025-03-31) — Interest Income: 630894000000.00
NMR cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 2879779000000.00
NMR balance_sheet (annual, 2025-03-31) — Invested Capital: 18355269000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 18355269000000.00
NMR cash_flow (annual, 2025-03-31) — Investing Cash Flow: -848647000000.00
NMR balance_sheet (annual, 2025-03-31) — Investments And Advances: 15243044000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 15243044000000.00
NMR cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 1412000000.00
NMR cash_flow (annual, 2025-03-31) — Issuance Of Debt: 6314986000000.00
NMR balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 174132000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 174132000000.00
NMR balance_sheet (annual, 2025-03-31) — Long Term Debt: 13767098000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 13767098000000.00
NMR balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13941230000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13941230000000.00
NMR cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 4464831000000.00
NMR cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -3337012000000.00
NMR balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 650639000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 650639000000.00
NMR balance_sheet (annual, 2025-03-31) — Minority Interest: 110120000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Minority Interest: 110120000000.00
NMR income_statement (annual, 2025-03-31) — Minority Interests: -6519000000.00
NMR income_statement (quarterly, 2025-03-31) — Minority Interests: -2004000000.00
NMR cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 8141000000.00
NMR cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -57594000000.00
NMR balance_sheet (annual, 2025-03-31) — Net Debt: 9369694000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Net Debt: 9369694000000.00
NMR income_statement (annual, 2025-03-31) — Net Income: 340736000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income: 71970000000.00
NMR income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 340736000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 71970000000.00
NMR income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 347255000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 73974000000.00
NMR income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 340736000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 71970000000.00
NMR income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 340736000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 71970000000.00
NMR cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 347255000000.00
NMR income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 347255000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 73974000000.00
NMR income_statement (annual, 2025-03-31) — Net Interest Income: 83603000000.00
NMR income_statement (quarterly, 2025-03-31) — Net Interest Income: 4275000000.00
NMR cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -168061000000.00
NMR cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1101080000000.00
NMR cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 1127819000000.00
NMR cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -36633000000.00
NMR cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 16154000000.00
NMR balance_sheet (annual, 2025-03-31) — Net PPE: 436454000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Net PPE: 436454000000.00
NMR cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -58893000000.00
NMR cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -26739000000.00
NMR balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3397534000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3397534000000.00
NMR balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 113820000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 113820000000.00
NMR balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 113820000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 113820000000.00
NMR income_statement (annual, 2025-03-31) — Normalized Income: 343719008000.00
NMR income_statement (quarterly, 2025-03-31) — Normalized Income: 71970000000.00
NMR income_statement (annual, 2025-03-31) — Occupancy And Equipment: 70166000000.00
NMR income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 17836000000.00
NMR cash_flow (annual, 2025-03-31) — Operating Cash Flow: -678611000000.00
NMR cash_flow (annual, 2025-03-31) — Operating Gains Losses: -32910000000.00
NMR income_statement (annual, 2025-03-31) — Operating Revenue: 1662374000000.00
NMR income_statement (quarterly, 2025-03-31) — Operating Revenue: 355223000000.00
NMR balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 2956210965.00
NMR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2956210965.00
NMR balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 1003527000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1003527000000.00
NMR balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 56146000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 56146000000.00
NMR cash_flow (annual, 2025-03-31) — Other Non Cash Items: 8503000000.00
NMR income_statement (annual, 2025-03-31) — Other Non Interest Expense: 436255000000.00
NMR income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 117637000000.00
NMR balance_sheet (annual, 2025-03-31) — Other Payable: 2766112000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Other Payable: 2766112000000.00
NMR balance_sheet (annual, 2025-03-31) — Other Receivables: 1230234000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1230234000000.00
NMR income_statement (annual, 2025-03-31) — Other Special Charges: 2344000000.00
NMR balance_sheet (annual, 2025-03-31) — Payables: 4231758000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Payables: 4231758000000.00
NMR balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 4782822000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4782822000000.00
NMR balance_sheet (annual, 2025-03-31) — Prepaid Assets: 28003000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 28003000000.00
NMR income_statement (annual, 2025-03-31) — Pretax Income: 471964000000.00
NMR income_statement (quarterly, 2025-03-31) — Pretax Income: 97744000000.00
NMR cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
NMR cash_flow (annual, 2025-03-31) — Purchase Of Investment: -322453000000.00
NMR cash_flow (annual, 2025-03-31) — Purchase Of PPE: -189971000000.00
NMR balance_sheet (annual, 2025-03-31) — Receivables: 1640956000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Receivables: 1640956000000.00
NMR income_statement (annual, 2025-03-31) — Reconciled Depreciation: 61653000000.00
NMR cash_flow (annual, 2025-03-31) — Repayment Of Debt: -5213906000000.00
NMR cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -59006000000.00
NMR income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 1914000000.00
NMR balance_sheet (annual, 2025-03-31) — Retained Earnings: 1867379000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1867379000000.00
NMR income_statement (annual, 2025-03-31) — Salaries And Wages: 732390000000.00
NMR income_statement (quarterly, 2025-03-31) — Salaries And Wages: 172321000000.00
NMR cash_flow (annual, 2025-03-31) — Sale Of Business: 8141000000.00
NMR cash_flow (annual, 2025-03-31) — Sale Of Investment: 154392000000.00
NMR cash_flow (annual, 2025-03-31) — Sale Of PPE: 131078000000.00
NMR income_statement (annual, 2025-03-31) — Selling General And Administration: 732390000000.00
NMR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 172321000000.00
NMR balance_sheet (annual, 2025-03-31) — Share Issued: 3163562601.00
NMR balance_sheet (quarterly, 2025-03-31) — Share Issued: 3163562601.00
NMR cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 1850155000000.00
NMR cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -1876894000000.00
NMR income_statement (annual, 2025-03-31) — Special Income Charges: -4053000000.00
NMR cash_flow (annual, 2025-03-31) — Stock Based Compensation: 38578000000.00
NMR balance_sheet (annual, 2025-03-31) — Stockholders Equity: 3470879000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3470879000000.00
NMR balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3397534000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3397534000000.00
NMR income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -1069992000.00
NMR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (annual, 2025-03-31) — Tax Provision: 124709000000.00
NMR income_statement (quarterly, 2025-03-31) — Tax Provision: 23770000000.00
NMR income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
NMR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
NMR balance_sheet (annual, 2025-03-31) — Total Assets: 56802170000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Assets: 56802170000000.00
NMR balance_sheet (annual, 2025-03-31) — Total Capitalization: 17237977000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 17237977000000.00
NMR balance_sheet (annual, 2025-03-31) — Total Debt: 15058522000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Debt: 15058522000000.00
NMR balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 3580999000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3580999000000.00
NMR balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 53221171000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 53221171000000.00
NMR balance_sheet (annual, 2025-03-31) — Total Tax Payable: 88424000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 88424000000.00
NMR income_statement (annual, 2025-03-31) — Total Unusual Items: -4053000000.00
NMR income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4053000000.00
NMR balance_sheet (annual, 2025-03-31) — Trading Securities: 13706013000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Trading Securities: 13706013000000.00
NMR balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 207351636.00
NMR balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 207351636.00
NMR balance_sheet (annual, 2025-03-31) — Treasury Stock: 143678000000.00
NMR balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 143678000000.00
NMR income_statement (quarterly, 2025-06-30) — +Total Revenue: 478537000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1545461000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 379901000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -534830000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 670541000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 655887000000.00
NMR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 2971653091.00
NMR income_statement (quarterly, 2025-06-30) — Basic EPS: 35.19
NMR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6047792000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 19012143000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Cash Financial: 4983234000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Common Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3476014000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Current Debt: 1322134000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1322134000000.00
NMR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3071827262.00
NMR income_statement (quarterly, 2025-06-30) — Diluted EPS: 34.04
NMR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 5953000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 401525000000.00
NMR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 186310000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Gross PPE: 949801000000.00
NMR income_statement (quarterly, 2025-06-30) — Interest Expense: 633273000000.00
NMR income_statement (quarterly, 2025-06-30) — Interest Income: 649561000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 19068381000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 25552384000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 14270233000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 14270233000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 662591000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Minority Interest: 112937000000.00
NMR income_statement (quarterly, 2025-06-30) — Minority Interests: -2909000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Net Debt: 9544575000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 107474000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 107474000000.00
NMR income_statement (quarterly, 2025-06-30) — Net Interest Income: 16288000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Net PPE: 414971000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3476014000000.00
NMR income_statement (quarterly, 2025-06-30) — Normalized Income: 104565000000.00
NMR income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 15965000000.00
NMR income_statement (quarterly, 2025-06-30) — Operating Revenue: 478537000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 2952497829.00
NMR balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1322134000000.00
NMR income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 115980000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Other Payable: 2501203000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Other Receivables: 976170000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Payables: 4046664000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4046664000000.00
NMR income_statement (quarterly, 2025-06-30) — Pretax Income: 160282000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Receivables: 1356071000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1963109000000.00
NMR income_statement (quarterly, 2025-06-30) — Salaries And Wages: 186310000000.00
NMR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 186310000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Share Issued: 3163562601.00
NMR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3476014000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3476014000000.00
NMR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NMR income_statement (quarterly, 2025-06-30) — Tax Provision: 52808000000.00
NMR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.33
NMR balance_sheet (quarterly, 2025-06-30) — Total Assets: 58101087000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 17746247000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Total Debt: 15592367000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3588951000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 54512136000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Trading Securities: 24233906000000.00
NMR balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 211064772.00
NMR balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 153654000000.00
NMR income_statement (quarterly, 2025-09-30) — +Total Revenue: 468271000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2054893000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 443129000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -557108000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 681968000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1066418000000.00
NMR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2938034461.00
NMR income_statement (quarterly, 2025-09-30) — Basic EPS: 31.34
NMR balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 163701000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 594493000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6831835000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 20232470000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Cash Financial: 5867361000000.00
NMR balance_sheet (quarterly, 2025-09-30) — Common Stock: 594493000000.00